The brain is a fragile organ that can be damaged by different impacts to the head, including sports injuries or car crashes. Thousands of people arediagnosed with traumatic brain injuries (TBI) each year,stemming from different head impacts. The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) awards 16 US institutions a TBI Model System grant each year to provide researchers and clinicians more opportunities to study these injuries.Read More
Science Market Update
Fighting cancer is a battle that milions of people have had to, or are currently, waging. When surgeons are unable to remove cancerous tumors, radiation treatment (radiotherapy) is used to destroy the tumors. However, many times, radiation treatments fail to destroy the entirety of the tumor, leaving cancerous cells in the body. Researchers at the Ichan School of Medicine at Mt. Sinai in New York have discovered why radiotherapy is not always successful.Read More
Tags: Mount Sinai School of Medicine, Northeast, New York, MSSM, BioResearch Product Faire Event, NY, fight cancer, radiation therapy, 2016, Icahn School of Medicine, radiotherapy, tisch cancer institute
The Mount Sinai Health System in New York, composed of a medical school and seven hospitals throughout New York City, is a leading institution in life science research. Scientists here frequently produce leading research results and publish beneficial papers to the life sciences. Within the medical school and the hospitals, there are dozens of research centers and institutes that perform this world-class research.Read More
Researchers at the Icahn School of Medicine at Mount Sinai University in New York have been studying how stress on fetal development is affected by different environmental toxins. The National Institute of Environmental Health Sciences (NIEHS) recently awarded Mount Sinai professor and researcher Manish Arora, BDS, PhD, MPH a $1.5 million New Innovator Award to help him continue this research. (Image on left courtesy of Wikimedia)Read More
There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines.Read More
Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East
Are you interested in reaching the $1.5 Billion New York laboratory sales and service marketplace?
Mount Sinai School of Medicine recently broke ground on a $125 million new building expansion and modernization project at Mount Sinai Queens. Construction began in October 2013 and is expected to be completed by 2016. The new building at Mount Sinai will house state-of-the-art operating rooms; an expanded emergency department; a multispecialty medical practice that includes primary care, specialty care, and urgent care; diagnostic and laboratory services; and medical offices that conduct on-site outpatient imaging.
“Cardiac surgery has been a spectacularly innovative field of medicine,” says the abstract of a Mount Sinai School of Medicine grant proposal on the NIH RePORTER. “The introduction of major innovations and ongoing incremental change have extended survival and improved quality of life for many patients suffering from cardiac disease. A rapid pace of innovation requires a rigorous infrastructure for clinical evaluation that provides timely assessments of the value of new treatments.”
With this winter's epic flu invasion maxing out emergency room space and leaving pharmacies without enough flu vaccine, influenza research is a hot topic in the news. Inquiring minds want to know: when will we have the tools to put this mutating foe out of commission once and for all? One very interesting approach to the problem of outsmarting the flu virus involves disrupting its timing by altering a critical protein it needs to exit the cell. At Mount Sinai School of Medicine in New York, microbiologist and virologist Benjamin R. tenOever recently published an article on his lab research into the molecular basis of virus pathogenicity in the journal Cell Reports. He was also interviewed by NPR just last week for their shots health news program, where he described the carefully-orchestrated maneuvering of the flu virus both into and out of the host cell by likening it to a bank robbery. If one part of the plan doesn't go off like clockwork, the gig is up.
Tags: 2014, Mount Sinai School of Medicine, 2013, Northeast, Virology, influenza research, New York, MSSM, BioResearch Product Faire Event, NY, New York City, Life Science Technology, lab supplier, Mt. Sinai
Mount Sinai School of Medicine in New York City has just celebrated the opening of its Leon and Norma Hess Center for Science and Medicine in Harlem, with no fewer than 6 full floors (180,000sf) dedicated to laboratory research. The 2 buildings that make up the research facilities and the residential/clinical tower have been under construction for four years, and when we last reported on their progress, the opening had been projected into Spring of 2013. Clearly they've made up some time and are eager to be fully operational as soon as possible. In fact, in a news release, officials said that they had originally expected it to take 4-5 years from the opening to a point where they were fully staffed (with new recruits), but now they've shortened that time to 18-24 months.